AJP - Regu Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol 274: R1406-R1416, 1998;
0363-6119/98 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lahaie, I.
Right arrow Articles by Chemtob, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lahaie, I.
Right arrow Articles by Chemtob, S.
Vol. 274, Issue 5, R1406-R1416, May 1998

A novel mechanism for vasoconstrictor action of 8-isoprostaglandin F2alpha on retinal vessels

Isabelle Lahaie1, Pierre Hardy1, Xin Hou1, Haroutioun Hasséssian2, Pierre Asselin1, Pierre Lachapelle3, Guillermina Almazan4, Daya R. Varma4, Jason D. Morrow5, L. Jackson Roberts II5, and Sylvain Chemtob1,4

1 Departments of Pediatrics, Ophthalmology, and Pharmacology, Research Center of Hôpital Sainte Justine, University of Montréal, 2 Department of Ophthalmology, Guy-Bernier Research Center of Hôpital Maisonneuve-Rosemont, University of Montréal, Montreal, Quebec H3T 1C5; 3 Department of Ophthalmology, Montreal Children's Hospital Research Center, McGill University, 4 Department of Pharmacology and Therapeutics, McGill University, Montreal, Quebec H3A 2B2, Canada; and 5 Departments of Pharmacology and Medicine, Vanderbilt University, Nashville, Tennessee 37232

Using a video-imaging technique, we characterized the effects of 8-isoprostaglandin F2alpha (8-iso-PGF2alpha ) on retinal vasculature from piglets. 8-Iso-PGF2alpha potently contracted (EC50 = 5.9 ± 0.5 nM) retinal vessels. These effects were completely antagonized by the cyclooxygenase inhibitor indomethacin, the thromboxane synthase blocker CGS-12970, the thromboxane receptor antagonist L-670596, and the putative inhibitor of the non-voltage-dependent receptor-operated Ca2+ pathway SKF-96365; constrictor effects of 8-iso-PGF2alpha were also partly attenuated by the ETA-receptor blocker BQ-123 and an inhibitor of endothelin-converting enzyme, phosphoramidon, but was negligibly affected by the L-type voltage-gated Ca2+ channel blocker nifedipine. Correspondingly, 8-iso-PGF2alpha elicited endothelin release from retinal preparations, which was markedly reduced by SKF-96365. 8-Iso-PGF2alpha also increased thromboxane production in the retina and cultured endothelial cells, but not on retinovascular smooth muscle cells; these effects of 8-iso-PGF2alpha were blocked by indomethacin, CGS-12970, SKF-96365, and EGTA, but not by nifedipine. 8-Iso-PGF2alpha also increased Ca2+ transients in retinal endothelial cells, which were inhibited by SKF-96365 and EGTA, but not by nifedipine, whereas in smooth muscle cells U-46619, but not 8-iso-PGF2alpha , stimulated a rise in Ca2+ transients. Finally, H2O2 + FeCl2 (in vitro) and anoxia followed by reoxygenation (in vivo) stimulated formation of 8-iso-PGF2alpha in the retina. In conclusion, 8-iso-PGF2alpha -induced retinal vasoconstriction is mediated by cyclooxygenase-generated formation of thromboxane and, to a lesser extent, by endothelin after Ca2+ entry into cells, possibly through receptor-operated channels. Retinal vasoconstriction to 8-isoprostanes might play a role in the genesis of ischemic retinopathies.

peroxidation; calcium influx; cyclooxygenase; thromboxane; endothelin


This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. Brault, F. Gobeil Jr., A. Fortier, J.-C. Honore, J.-S. Joyal, P. S. Sapieha, A. Kooli, E. Martin, P. Hardy, A. Ribeiro-da-Silva, et al.
Lysophosphatidic acid induces endothelial cell death by modulating the redox environment
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2007; 292(3): R1174 - R1183.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
G. Cambonie, B. Comte, C. Yzydorczyk, T. Ntimbane, N. Germain, N. L. O. Le, P. Pladys, C. Gauthier, I. Lahaie, D. Abran, et al.
Antenatal antioxidant prevents adult hypertension, vascular dysfunction, and microvascular rarefaction associated with in utero exposure to a low-protein diet
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2007; 292(3): R1236 - R1245.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
W. J. Welch
Effects of isoprostane on tubuloglomerular feedback: roles of TP receptors, NOS, and salt intake
Am J Physiol Renal Physiol, April 1, 2005; 288(4): F757 - F762.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. Catalli and L. J. Janssen
Augmentation of bovine airway smooth muscle responsiveness to carbachol, KCl, and histamine by the isoprostane 8-iso-PGE2
Am J Physiol Lung Cell Mol Physiol, November 1, 2004; 287(5): L1035 - L1041.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
J. Belik, R. P. Jankov, J. Pan, M. Yi, C. R. Pace-Asciak, and A. K. Tanswell
Effect of 8-isoprostaglandin F2{alpha} on the newborn rat pulmonary arterial muscle and endothelium
J Appl Physiol, November 1, 2003; 95(5): 1979 - 1985.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. Catalli, D. Zhang, and L. J. Janssen
Receptors and signaling pathway underlying relaxations to isoprostanes in canine and porcine airway smooth muscle
Am J Physiol Lung Cell Mol Physiol, November 1, 2002; 283(5): L1151 - L1159.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. Balazy, T. Iesaki, J. L. Park, H. Jiang, P. M. Kaminski, and M. S. Wolin
Vicinal Nitrohydroxyeicosatrienoic Acids: Vasodilator Lipids Formed by Reaction of Nitrogen Dioxide with Arachidonic Acid
J. Pharmacol. Exp. Ther., November 1, 2001; 299(2): 611 - 619.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
D. H. Wright, D. Abran, M. Bhattacharya, X. Hou, S. G. Bernier, A. Bouayad, J.-C. Fouron, A. Vazquez-Tello, M. H. Beauchamp, R. I. Clyman, et al.
Prostanoid receptors: ontogeny and implications in vascular physiology
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2001; 281(5): R1343 - R1360.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
X. Hou, L. J. Roberts II, D. F. Taber, J. D. Morrow, K. Kanai, F. Gobeil Jr., M. H. Beauchamp, S. G. Bernier, G. Lepage, D. R. Varma, et al.
2,3-Dinor-5,6-dihydro-15-F2t-isoprostane: a bioactive prostanoid metabolite
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2001; 281(2): R391 - R400.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
M. H. Beauchamp, A. K. Martinez-Bermudez, F. Gobeil Jr., A. M. Marrache, X. Hou, G. Speranza, D. Abran, C. Quiniou, P. Lachapelle, J. Roberts II, et al.
Role of thromboxane in retinal microvascular degeneration in oxygen-induced retinopathy
J Appl Physiol, June 1, 2001; 90(6): 2279 - 2288.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
L. J. Janssen
Isoprostanes: an overview and putative roles in pulmonary pathophysiology
Am J Physiol Lung Cell Mol Physiol, June 1, 2001; 280(6): L1067 - L1082.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
T. Najarian, A. M. Marrache, I. Dumont, P. Hardy, M. H. Beauchamp, X. Hou, K. Peri, F. Gobeil Jr, D. R. Varma, and S. Chemtob
Prolonged Hypercapnia-Evoked Cerebral Hyperemia via K+ Channel- and Prostaglandin E2-Dependent Endothelial Nitric Oxide Synthase Induction
Circ. Res., December 8, 2000; 87(12): 1149 - 1156.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. G. Schnackenberg and C. S. Wilcox
Two-Week Administration of Tempol Attenuates Both Hypertension and Renal Excretion of 8-Iso Prostaglandin F2{alpha}
Hypertension, January 1, 1999; 33(1): 424 - 428.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online